White Paper: Veeva — Building a Compliant Content Foundation for the Future
Industry data estimates that by 2026, first-time biotech launches will outnumber those from established companies by more than two to one. Emerging biotechs are moving beyond historically common licensing, partnership, and acquisition paths to launch products themselves. Success in this landscape requires strong foundational content...
White Paper: Embrace The Era of Continuous Measurement
We are in the age of technological proliferation. The way we work is being revolutionized. We have access to more data than ever before. And now, we are under significant expectations to deliver speed: from speed of development to speed of delivery to speed of execution. What if we could deliver speed of measurement? What if the...
White Paper: New Training Approaches to Advance Strategic Skills for Medical Science Liaisons
The Medical Science Liaison (MSL) role is rapidly evolving, and MSL training must evolve with it. According to field leaders, MSLs are increasingly interacting with new kinds of external stakeholders, driving insight generation and supporting strategic company goals through internal deployment of insights, which requires MSLs to utilize a high...
White Paper: How to Activate Life Science Consumers with Telehealth
The life science industry is experiencing a golden age of innovation, but activating consumers with effective commercialization strategies is becoming more challenging. How can we bridge the gap between innovative treatments and the consumers pharma brands are trying to reach? This report reveals how DTC...
White Paper: Ingredients For Successful Physician Email Campaigns
This whitepaper is a comprehensive guide designed to assist healthcare marketers in executing successful email campaigns targeting physicians. The whitepaper emphasizes the importance of accurate data, understanding physician preferences, and adhering to regulatory standards. It outlines methods to optimize email communications, ensuring high...
White Paper: The Co-pay Assistance Workflow is Broken
The higher the price of a prescription, the more likely a patient is to abandon their treatment. Even though improving patient affordability and access to drugs is a top priority for many in the healthcare field, only 10% of patient assistance dollars get utilized due to broken workflows and outdated technology. Pharmacists, HCPs, hubs, PBMs,...
White Paper - Advanced AAV Antibody Testing: Pioneering Precision in Gene Therapy
Enhance Your Gene Therapy Strategy with Key AAV Insights Gene therapy is advancing rapidly, with adeno-associated virus (AAV) vectors at the forefront, offering hope for patients with genetic disorders. However, the success of these therapies hinges on a crucial aspect that can no longer be overlooked—immunogenicity. "Advanced AAV Antibody...
Whitepaper: Mastering the Omnichannel Approach
For brands and their customers, the traditional path to conversion no longer applies To achieve success, mastering the omnichannel approach demands a deep understanding of the target audience’s decision journey and the creation of a learning system capable of providing relevant content. Whether navigating the complexities of pharma journeys,...
Whitepaper: Preparing for the At-home Diagnostic Testing Revolution
Three best practices for building stronger connections with patients. In the aftermath of the COVID-19 pandemic, the landscape of healthcare and life sciences has undergone a significant transformation, with at-home diagnostic testing emerging as a key innovation reshaping patient expectations and care. The "Preparing for the At-Home Diagnostic...
Whitepaper: Strategies to Maximize Customer Engagement
Simplify to amplify: “Declutter” your current Customer Engagement approach to maximize value In today's rapidly evolving healthcare landscape, effective customer engagement strategies are pivotal for success, and now more than ever, pharmaceutical companies must adapt to maximize value. Download this insightful whitepaper authored...
Whitepaper - The path to success in precision medicine: market access for CDx
Discover the patterns that emerge from real-world CDx development and post-approval projects. Struggling to achieve the widespread adoption of your precision medicine therapy? The missing piece might be the commercialization of your companion diagnostic (CDx). Historical underinvestment in CDx commercialization and inadequate reimbursement policies...
Whitepaper: Accelerate Launch Readiness
How to Right-size Omnichannel Capabilities for Pharma Innovators Omnichannel marketing capabilities directed at HCPs and patients are one domain within a marketer’s control, and can contribute significantly to launch success. With the right partner and a lean approach, you can gain effectiveness and efficiency by using existing, proven...
Whitepaper: The Holy Grail of Winning HCP Attention
AI-Driven Patient-First Engagement Pharma marketers are investing in powerful next-best-action (NBA) strategies to engage healthcare providers (HCPs) – and nothing is more actionable than knowing when your brand-eligible patient is with their HCP. How do patient care and milestone predictions transform HCP marketing? This...
